Cinacalcet ( DrugBank: Cinacalcet )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 238 | ビタミンＤ抵抗性くる病/骨軟化症 | 3 |
238. ビタミンＤ抵抗性くる病/骨軟化症
臨床試験数 : 29 / 薬物数 : 25 - (DrugBank : 11) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01748812 (ClinicalTrials.gov) | November 16, 2012 | 11/12/2012 | Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets) | Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia | Osteomalacia | Drug: Osteomalacia | National Institute of Dental and Craniofacial Research (NIDCR) | NULL | Terminated | 18 Years | 70 Years | All | 1 | Phase 1 | United States |
| 2 | NCT00844740 (ClinicalTrials.gov) | February 2009 | 12/2/2009 | Calcimimetics in Hypophosphatemic Rickets | Effect of Cinacalcet on the Long-Term Treatment of Familial Hypophosphatemic Rickets | Familial Hypophosphatemic Rickets | Drug: Cinacalcet | Children's Mercy Hospital Kansas City | NULL | Enrolling by invitation | 5 Years | 21 Years | Both | 10 | N/A | United States |
| 3 | NCT00195936 (ClinicalTrials.gov) | June 2005 | 13/9/2005 | Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets | Effect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic Rickets | Hypophosphatemic Rickets, X-Linked Dominant | Drug: Cinacalcet | Children's Mercy Hospital Kansas City | NULL | Completed | 5 Years | N/A | All | 8 | Phase 1 | United States |